School of Pharmacy, Fujian Provincial Key Laboratory of Natural Medicine Pharmacology, Fujian Medical University, Fuzhou, China.
Department of Pharmacy, Shanghai Skin Disease Hospital, Shanghai, China.
Nat Prod Res. 2022 Mar;36(5):1396-1399. doi: 10.1080/14786419.2021.1878514. Epub 2021 Mar 10.
Two sterols and seven triterpenoids were isolated and identified from by silica gel column chromatography, preparative high-performance liquid chromatography and spectra analysis. Then, the multidrug resistance reversal activities of these compounds were assessed using MTT assay. Among these compounds, ganoderol B (), ganoderone A (), ganodermanondiol () and ganoderiol F () were shown to reverse the resistance of human oral epidermoid carcinoma cell line KBv200 to doxorubicin, and the reversal folds were 6.59, 4.70, 4.01 and 7.09, respectively. Ganoderiol F could increase the intracellular accumulation of doxorubicin in KBv200 cells through inhibiting P-glycoprotein transport function. Further mechanistic investigation found that ganoderiol F did not alter P-glycoprotein expression. In conclusion, ganoderiol F has potent effect in reversing P-glycoprotein mediated tumor multidrug resistance. Potential reversal agents against multidrug resistance in tumor may be found in triterpenoids from .[Formula: see text].
从 中通过硅胶柱层析、制备高效液相色谱和光谱分析分离鉴定了两种甾体和七种三萜类化合物。然后,通过 MTT 法评估了这些化合物的多药耐药逆转活性。在这些化合物中,灵芝醇 B()、灵芝酮 A()、灵芝酸 D()和灵芝醇 F()被证明能够逆转人口腔表皮样癌细胞系 KBv200 对阿霉素的耐药性,逆转倍数分别为 6.59、4.70、4.01 和 7.09。灵芝醇 F 可以通过抑制 P-糖蛋白转运功能增加 KBv200 细胞内阿霉素的积累。进一步的机制研究发现,灵芝醇 F 不会改变 P-糖蛋白的表达。总之,灵芝醇 F 具有逆转 P-糖蛋白介导的肿瘤多药耐药的强大作用。灵芝中的三萜类化合物可能是潜在的针对肿瘤多药耐药的逆转剂。